![Saul Priceman: Phase 1 trial with PSCA-CAR T cell therapy in patients with mCRPC](https://oncodaily.com/pub/uploads/2024/05/1714774131774.png)
Photo of Saul Priceman from Caryn Lerman/LinkedIn
Jun 15, 2024, 07:37
Saul Priceman: Phase 1 trial with PSCA-CAR T cell therapy in patients with mCRPC
Saul Priceman, Associate Professor at City of Hope, made the following post on X:
“Proud of our work published today in Nature Medicine, sharing results from our phase 1 trial with PSCA-CAR T cell therapy in patients with mCRPC. Big collaborations work Tanya Dorff, Stephen Forman, Peter Kuhn, Lior Pachter! Thank you Prostate Cancer Foundation for your support!”
Read further.
Source: Saul Priceman/X
Jun 23, 2024, 14:23